If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

The danger and hardship gets worse by the day for civilians in eastern Ukraine. Still, they resist leaving the places that have become their homes. By Tyler Hicks and Gaëlle Girbes Human rights ...

Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, says he was close to the departure lounge when it was hit. Ukraine's air force says it detected 184 missiles and ...

Musk and Ramaswamy have found themselves at odds with some of Trump's supporters over their support for H-1B visas, which allow foreign professionals to work in America. Wembanyama has 19 points ...